Young biotech startups can benefit hugely from the US National Institutes of Health (NIH), not least because of the agency's non-dilutive funding, guidance, and opportunities for collaboration. Increasingly, however, there is a fair bit of misunderstanding about what the NIH can and cannot do for a biotech entrepreneur.
- GIL BEN-MENACHEM
- STEVEN M. FERGUSON
- KRISHNA BALAKRISHNAN
